Loading viewer...
conference
Format: PDF conference
Karyopharm Therapeutics presented at the HC Wainwright 26th Annual Global Investment Conference in September 2024, discussing selinexor (XPOVIO) development and commercialization. The presentation covers the company's refinancing transactions, 2024 financial guidance, and clinical development plans for selinexor across multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma.
conference
80 Pages
conference
45 Pages
Continental Resources
Lincoln National Corporation 2016 Goldman Sachs Financial Services
conferenceconference
39 Pages
Lincoln National Corporation
Stanley Black & Decker 2021 Raymond James Investor Conference
conferenceconference
6 Pages
Stanley Black & Decker